Modeling healthcare quality: life expectancy SURS in the G7 countries and Korea

In this study I have made efforts towards investigating healthcare in two arenas. First, can a model with life expectancy as a proxy for healthcare quality be used to objectify the study of efficiency in the G7 countries and Korea? Table 1 and the results section have illuminated many factor variables which vary between countries and characterize the environments in which different healthcare systems have developed. The analysis also illuminates an inherent structural difference in the mechanism of delivering healthcare throughout the developed world. Secondly, can these aggregate data be used to show us anything new about the studies performed by Peter Zweifel and Friedrich Breyer? Did the SISYPHUS Syndrome disappear in the early 1990s as Zweifel suggested in 2002? No, in Table 2 I have demonstrated through SURS that over the time period 1990-2009 there are clear statistically significant SISYPH variables in at least Canada, Germany, Korea, and Britain. Lastly, can I confirm Breyer’s model of HCE in Germany and can it be useful in other countries? Yes to extent possible the methodologies were replicated in a SURS fashion in an effort to simultaneously test and examine different variables in different countries. I was unable to confirm the results of Breyer in his 2011 examination of the sickness fund members for Germany. However, I was able to offer primitive characterizations of the other G7 countries and Korea and how their HCE move.